Randomised trial of intrapleural urokinase in the treatment of childhood empyema.
BACKGROUND: The role of intrapleural fibrinolytic agents in the treatment of childhood empyema has not been established. A randomised double blind placebo controlled trial of intrapleural urokinase was performed in children with parapneumonic empyema. METHODS: Sixty children (median age 3.3 years) w...
Main Authors: | Thomson, A, Hull, J, Kumar, MR, Wallis, C, Balfour Lynn, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
Randomised trial of intrapleural urokinase in the treatment of childhood empyema
by: Thomson, A, et al.
Published: (2000) -
Urokinase in the treatment of childhood empyema - Author's reply
by: Thomson, A, et al.
Published: (2003) -
Phase I trial of the single-chain urokinase intrapleural LTI-01 in complicated parapneumonic effusions or empyema
by: Beckert, L, et al.
Published: (2019) -
Intrapleural and plasma processing of LTI-01 (single chain urokinase Plasminogen Activator, scuPA) in a phase 1b trial of LTI-01 Intrapleural Fibrinolytic Therapy (IPFT) in patients with Complicated Parapneumonic Effusions (CPE) or empyema
by: Komissarov, A, et al.
Published: (2019) -
Phase 1b Trial of LTI-01 (Single Chain Urokinase Plasminogen Activator, scuPA) Intrapleural Fibrinolytic Therapy (IPFT) in Patients with Complicated Parapneumonic Effusions (CPE) or Empyema
by: Idell, S, et al.
Published: (2019)